GO
Loading...

Allergan Inc

More

  • Final Glance: Medical Devices companies Thursday, 31 Jul 2014 | 6:04 PM ET

    Allergan fell $6.31 or 3.7 percent, to $165.86. Baxter International Inc. fell $1.40 or 1.8 percent, to $74.69. Boston Scientific Corp. fell$. 36 or 2.7 percent, to $12.78.

  • Valeant forecast overshadows strong quarter Thursday, 31 Jul 2014 | 1:04 PM ET

    Shares of Valeant Pharmaceuticals plunged 7 percent Thursday after the company slashed its earnings and revenue forecasts. The Canadian drugmaker now expects 2014 earnings to range between $7.90 and $8.10 per share, down from a forecast it made in April for $8.55 to $8.80 per share.

  • July 31- Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, on Thursday cut its 2014 and 2015 profit forecasts, sending shares 10 percent lower.

  • UPDATE 1-Allergan-bidder Valeant cuts 2014 outlook Thursday, 31 Jul 2014 | 7:54 AM ET

    July 31- Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, cut its full-year profit and revenue forecasts to reflect the sale of its rights to several skincare products.

  • Final Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 6:02 PM ET

    Allergan rose $1.27 or. 7 percent, to $172.17. Baxter International Inc. fell$. 25 or. 3 percent, to $76.09. Boston Scientific Corp. rose$. 25 or 1.9 percent, to $13.14.

  • Midday Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Allergan rose $1.25 or. 7 percent, to $172.15. Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $13.07.

  • Early Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Allergan rose $1.15 or. 7 percent, to $172.05. Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Boston Scientific Corp. rose$. 02 or. 2 percent, to $12.91.

  • Final Glance: Medical Devices companies Monday, 28 Jul 2014 | 6:04 PM ET

    Allergan rose$. 09 or. 1 percent, to $170.15. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97. Medtronic fell$. 14 or. 2 percent, to $62.76.

  • Midday Glance: Medical Devices companies Monday, 28 Jul 2014 | 1:31 PM ET

    Allergan fell$. 02 or percent, to $170.04. Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Boston Scientific Corp. fell$. 20 or 1.5 percent, to $12.91.

  • Early Glance: Medical Devices companies Monday, 28 Jul 2014 | 10:33 AM ET

    Allergan rose$. 55 or. 3 percent, to $170.61. Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97.

  • July 25- Allergan Inc, known best for its Botox wrinkle treatment, said on Friday that European Union regulators had recommended use of its eye drug Ozurdex be extended to treat patients with diabetic macular edema.

  • Final Glance: Medical Devices companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Allergan fell $1.86 or 1.1 percent, to $170.57. Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • Midday Glance: Medical Devices companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Allergan fell$. 78 or. 5 percent, to $171.65. Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Boston Scientific Corp. rose$. 09 or. 7 percent, to $13.11.

  • Early Glance: Medical Devices companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Allergan fell $1.51 or. 9 percent, to $170.92. Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Boston Scientific Corp. rose$. 02 or. 2 percent, to $13.04.

  • Republican lawmaker to grill U.S. SEC over Ackman tactics Thursday, 24 Jul 2014 | 12:01 AM ET

    WASHINGTON, July 24- A U.S. lawmaker will pressure the U.S. Securities and Exchange Commission on Thursday to consider a raft of reforms, after William Ackman's aggressive efforts to take over Allergan Inc raised concerns about loose rules governing disclosure and shareholder voting.

  • Ackman's clients shrug off Herbalife embarrassment Wednesday, 23 Jul 2014 | 2:53 PM ET
    Bill Ackman

    Pershing Square Capital Management clients aren't very concerned about Herbalife's big gain yesterday.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Business Highlights Monday, 21 Jul 2014 | 6:01 PM ET

    Microsoft makes design central to its future. Before Ralf Groene helped devise the look and feel of Microsoft's Surface tablet, he designed food— or "food concepts," he says, such as dried noodles that come wrapped around a pair of chopsticks and a fork that squeezes out sauce.

  • Ackman: Why I think Herbalife is going to collapse Monday, 21 Jul 2014 | 5:03 PM ET
    Bill Ackman

    Bill Ackman, head of Pershing Square Capital Management, said his firm's presentation of a Herbalife investigation will "expose incredible fraud."